Ian Beales is a Clinical Senior Lecturer in Cell Biology and Gastroenterology at the University of East Anglia. He has published several papers in F1000Research, and is taking full advantage of the fact that we publish all sound science – not necessarily only large groundbreaking research projects. In this interview, he talks about the work he…
In a recent Industry Forum report by Thomson Reuters, several pertinent statements were made: The growing accumulation of data produced by academics which is not destined for publication represents an impediment to scientific progress. Conventional research assessment methods do not recognise or reward data sharing. A researcher’s overall contribution to scientific progress is greater than…
For nearly 300 years, peer review has been the main arbiter of regulating scientific quality and maintaining academic integrity. Articles have to be evaluated and satisfy appointed reviewers before they are rubber-stamped into the scientific record, so peer review is unquestionably an indispensable step of the publishing process. As we know ‘peers’ are fellow scientists:…
A few weeks ago, a group of Georgetown, McDonough School of Business MBAs contacted F1000Research to ask about our ongoing campaign to encourage the publication of negative results. They’re trying to develop a way to make it easier for researchers to share negative data. Below, you can find out more about the project from Dennis…
Today, BioMed Central announced that they will require authors to make all data associated with published articles available under a Creative Commons CC0 waiver. This is great news, as it places more biomedical data in the public domain, helping others to reuse data from peer-reviewed papers more efficiently. It’s the same legal tool that our…
Over the past months, we’ve been discussing the publication of negative results, and some of the obstacles that prevent people from publishing them. While we’re happy to publish papers based on negative results, not everyone can find the time to write them up. A Dutch funding agency is now giving out grants specifically to fund…
We cover all areas of life sciences, but we know that different fields each have their own unique characteristics, and some features of our journal are of particular interest to certain disciplines. For the coming months, one area we’ll be focussing on is ecology. To encourage ecologists to try F1000Research, we’re waiving the article processing…
Mautusi Mitra’s lab recently characterized two novel Chlamydomonas mutants that are defective in chlorophyll biosynthesis. You can read both her papers on F1000Research, but in this video she provides a quick summary of the work: In the video, Mitra also outlines the main reasons for submitting these papers to F1000Research, transcribed below. Speed was an…
A few months ago, we announced a grace period to submit your negative results papers for free until the end of August. The news spread far and wide, and we’ve had amazing feedback. Many of you were relieved to know that there *is* a home for negative results, and you agreed with us that all…
Online publication should make publishing faster, but it still takes months to get a paper published. In competitive fields, it’s not unlikely that the credit for the first published paper on a new discovery doesn’t necessarily go to the researcher who was the first to complete the work, but to the one who happened to…
